Sunil Healthcare P/E Ratio
Sunil Healthcare P/E ratio. Sunil Healthcare (SUNLOC) P/E ratio is 20.2 (Moderate), EPS (TTM) ₹3.91, current price ₹68.00 on NSE vs historical average P/E of 26.1 — High - Growth expectations or overvalued. Also explore Sunil Healthcare stock price data download to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SUNLOC P/E Ratio — Valuation Signal & Historical Context
Sunil Healthcare P/E 20.2 vs historical average 26.1, range 26.1–26.1 — signal: Overvalued. Examine SUNLOC Q4 results for recent quarterly revenue, profit and EPS trends.
- Current PE is 22.6% below historical average
- Trading at discount to sector average PE of 55.85
Sunil Healthcare P/E Ratio Historical Trend
SUNLOC annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 20.2 vs historical average 26.1. For live price, revenue and the complete fundamental profile, see SUNLOC screener.
SUNLOC Historical P/E Ratio — EPS, Year-End Price & Valuation
Sunil Healthcare annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 26.1 | 2.78 | ₹72.55 | BSE | High |
SUNLOC vs Healthcare Peers — P/E Ratio Comparison
Sunil Healthcare P/E 20.2 vs Healthcare average 55.85, median 31.7 — range 2.07–740.29.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.07 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.28 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.78 | ₹65 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹46 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |